Jun Tang

10PUBLICATIONS
17CO-AUTHORS
Predictive and prognostic markersInnate immunityMolecular targetsTumour immunologyModels of care and place of birth
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 30, 2026
Optimizing the ER Cutoff in HER2-Positive Breast Cancer: ER ≥ 50% Predicts Low pCR Rates and Resistance to Antibody-Drug Conjugates in the Neoadjuvant Setting.

|May 16, 2026
Germline Pathogenic Variants in HER2-Positive Breast Cancer: Spectrum and Clinical Implications in a High-Risk Chinese Cohort.

|Apr 14, 2025
Targeting site-specific N-glycosylated B7H3 induces potent antitumor immunity.

Yun Huang, Wen-Qing Zhong, Xiao-Yu Yang

|Jun 20, 2024
Comprehensive pan-cancer analysis of mitochondrial outer membrane permeabilisation activity reveals positive immunomodulation and assists in identifying potential therapeutic targets for immunotherapy resistance.

Qingshan Chen, Fenglin Gao, Junwan Wu

|Feb 05, 2023
Evolutionary route of nasopharyngeal carcinoma metastasis and its clinical significance.

Mei Lin, Xiao-Long Zhang, Rui You

|Oct 18, 2021
A Novel Systematic Oxidative Stress Score Predicts the Prognosis of Patients with Operable Breast Cancer.

Kaiming Zhang, Liqin Ping, Tian Du

Pageof 2

Frequent Collaborators

3 joint publications

Zhi-Ling Li

3 joint publications

Rong Deng

3 joint publications

Tian Du

2 joint publications

Xiao-Feng Zhu